Biopsy-site Marker Effects in Breast Cancer
Biopsy-site-marker in Breast Cancer
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 140 (estimated)
- Sponsor
- University of Oklahoma · Other
This trial is looking for women over 18 who have been diagnosed with invasive breast cancer. Participants will help researchers understand how the stiffness of a biopsy site marker might affect inflammation in breast cancer.
You may be able to join if
- I have signed a consent form to participate.
- I am a female over 18 years old.
- I have been diagnosed with invasive breast cancer.
You may not be able to join if
- I have had a biopsy at OUBI OKC.
- I am going to receive neoadjuvant therapy.
- I have uncontrolled high blood pressure or diabetes.
- I am currently pregnant or breastfeeding.
- I am not eligible for surgery.
- I am a prisoner.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.
Loading trial locations…